Cholestatic jaundice caused by D-penicillamine.
Open Access
- 1 February 1978
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 37 (1) , 98-100
- https://doi.org/10.1136/ard.37.1.98
Abstract
D-penicillamine is not generally considered to cause hepatic damage. Cholestatic jaundice developed in a patient with rheumatoid arthritis 4 weeks after penicillamine was added to his regimen, and he died in acute renal failure. The probability that penicillamine caused the cholestasis is discussed.This publication has 16 references indexed in Scilit:
- D-Penicillamine Induced Goodpasture's Syndrome in Wilson's DiseaseAnnals of Internal Medicine, 1975
- Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis.BMJ, 1975
- Aspirin HepatitisAnnals of Internal Medicine, 1974
- Aspirin-Induced Hepatotoxicity in Patients with Systemic Lupus ErythematosusAnnals of Internal Medicine, 1974
- CONTROLLED TRIAL OF D(-)PENICILLAMINE IN SEVERE RHEUMATOID ARTHRITISThe Lancet, 1973
- Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritisArthritis & Rheumatism, 1973
- Lupus-like Syndrome Induced by Penicillamine In CystinuriaPublished by American Medical Association (AMA) ,1972
- Serum transaminases and salicylate therapy.BMJ, 1972
- Serum Transaminases during Salicylate TherapyBMJ, 1971
- Extreme HyperbilirubinemiaArchives of internal medicine (1960), 1971